Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and FutureRenaud Heine, Carin A. Uyl‐de Groot, Marc Koopmanschap et al.|HemaSphere|2021Cited by 52